Using Machine Learning to Individualize Treatment Effect Estimation: Challenges and Opportunities
Top Cited Papers
Open Access
- 12 January 2024
- journal article
- review article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 115 (4) , 710-719
Abstract
The use of data from randomized clinical trials to justify treatment decisions for real‐world patients is the current state of the art. It relies on the assumption that average treatment effects from the trial can be extrapolated to patients with personal and/or disease characteristics different from those treated in the trial. Yet, because of heterogeneity of treatment effects between patients and between the trial population and real‐world patients, this assumption may not be correct for many patients. Using machine learning to estimate the expected conditional average treatment effect (CATE) in individual patients from observational data offers the potential for more accurate estimation of the expected treatment effects in each patient based on their observed characteristics. In this review, we discuss some of the challenges and opportunities for machine learning to estimate CATE, including ensuring identification assumptions are met, managing covariate shift, and learning without access to the true label of interest. We also discuss the potential applications as well as future work and collaborations needed to further improve identification and utilization of CATE estimates to increase patient benefit.Keywords
This publication has 51 references indexed in Scilit:
- From concepts, theory, and evidence of heterogeneity of treatment effects to methodological approaches: a primerBMC Medical Research Methodology, 2012
- Examining the Evidence: A Systematic Review of the Inclusion and Analysis of Older Adults in Randomized Controlled TrialsJournal of General Internal Medicine, 2011
- Bayesian Nonparametric Modeling for Causal InferenceJournal of Computational and Graphical Statistics, 2011
- Overadjustment Bias and Unnecessary Adjustment in Epidemiologic StudiesEpidemiology, 2009
- Dealing with heterogeneity of treatment effects: is the literature up to the challenge?Trials, 2009
- Randomized Controlled Trials: Do They Have External Validity for Patients With Multiple Comorbidities?The Annals of Family Medicine, 2006
- Causal Inference Using Potential OutcomesJournal of the American Statistical Association, 2005
- Differences between clinical trials and postmarketing useBritish Journal of Clinical Pharmacology, 2003
- Statistics and Causal InferenceJournal of the American Statistical Association, 1986
- The central role of the propensity score in observational studies for causal effectsBiometrika, 1983